Journal article icon

Journal article

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

Abstract:
Background & Aim Primary sclerosing cholangitis (PSC) represents a devastating bile duct disease, currently lacking effective medical therapy. 24-norursodeoxycholic acid (norUDCA) is a side chain-shortened C23 homologue of UDCA and has shown potent anti-cholestatic, anti-inflammatory and anti-fibrotic properties in a preclinical PSC mouse model. A randomized controlled trial, including 38 centers from 12 European countries, evaluated the safety and efficacy of three doses... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/j.jhep.2017.05.009

Authors


More by this author
Role:
Author
ORCID:
0000-0002-6736-2255
Expand authors...
Publisher:
Elsevier Publisher's website
Journal:
Journal of Hepatology Journal website
Volume:
67
Issue:
3
Pages:
549-558
Publication date:
2017-05-18
Acceptance date:
2017-05-06
DOI:
EISSN:
1600-0641
ISSN:
0168-8278
Pmid:
28529147
Source identifiers:
900890
Language:
English
Keywords:
Pubs id:
pubs:900890
UUID:
uuid:8a82ad46-7070-46f2-bf70-23d149e84a68
Local pid:
pubs:900890
Deposit date:
2019-01-30

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP